Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 27;15(3):778.
doi: 10.3390/cancers15030778.

Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer

Affiliations
Review

Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer

Harald Rosen et al. Cancers (Basel). .

Abstract

Introduction: A total of 60-80% of patients undergoing rectal resection (mostly as a treatment for rectal cancer) suffer from a variety of partly severe functional problems despite preservation of the anal sphincter. These patients are summarized under the term low anterior resection syndrome (LARS). Preoperative radiotherapy, vascular dissection and surgical excision of the low rectum and mesorectum lead, alone or all together, to a significant impairment of colonic and (neo-) rectal motility. This results in a variety of symptoms (multiple defecation episodes, recurrent episodes of urge, clustering, incontinence, etc.) which are associated with severe impairment of quality of life (QOL).

Methods: This narrative review summarizes the present state of knowledge regarding the pathophysiology of LARS as well as the evidence for the available treatment options to control the symptoms resulting from this condition.

Results: A review of the literature (Medline, Pubmed) reveals a variety of treatment options available to control symptoms of LARS. Medical therapy, with or without dietary modification, shows only a modest effect. Pelvic floor rehabilitation consisting of muscle exercise techniques as well as biofeedback training has been associated with improvement in LARS scores and incontinence, albeit with limited scientific evidence. Transanal irrigation (TAI) has gained interest as a treatment modality for patients with LARS due to an increasing number of promising data from recently published studies. Despite this promising observation, open questions about still-unclear issues of TAI remain under debate. Neuromodulation has been applied in LARS only in a few studies with small numbers of patients and partly conflicting results.

Conclusion: LARS is a frequent problem after sphincter-preserving rectal surgery and leads to a marked impairment of QOL. Due to the large number of patients suffering from this condition, mandatory identification, as well as treatment of affected patients, must be considered during surgical as well as oncological follow-up. The use of a standardized treatment algorithm will lead to sufficient control of symptoms and a high probability of a marked improvement in QOL.

Keywords: low anterior resection syndrome; rectal resection; transanal irrigation.

PubMed Disclaimer

Conflict of interest statement

H.R. is member of the Advisory Board for LARS of Coloplast. Coloplast was not financially involved in the production of this article. Other authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Bowel rehabilitation program (BOREAL) [45].

Similar articles

Cited by

References

    1. Monson J., Weiser M., Buie W., Chang G.J., Rafferty J.F., Buie W.D., Rafferty J., Guillem J., Boushey R., Chang G., et al. Practice parameters for the management of rectal cancer (revised) Dis. Colon Rectum. 2013;56:535–550. doi: 10.1097/DCR.0b013e31828cb66c. - DOI - PubMed
    1. Renner K., Rosen H.R., Novi G., Hölbling N., Schiessel R. Quality of life after surgery for rectal cancer: Do we still need a permanent colostomy? Dis. Colon Rectum. 1994;42:1160–1167. doi: 10.1007/BF02238568. - DOI - PubMed
    1. Dekker E., Tanis P.J., Vleugels J.L.A., Kasi P.M., Wallace M.B. Colorectal cancer. Lancet. 2019;394:1467–1480. doi: 10.1016/S0140-6736(19)32319-0. - DOI - PubMed
    1. Brännström F., Bjerregaard J.K., Winbladh A., Nilbert M., Revhaug A., Wagenius G., Mörner M. Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer. Acta Oncol. 2015;54:447–453. doi: 10.3109/0284186X.2014.952387. - DOI - PubMed
    1. Kong J.C., Soucisse M., Michael M., Tie J., Ngan S.Y., Leong T., McCormick J., Warrier S.K., Heriot A.G. Total neoadjuvant therapy in locally advanced rectal cancer: A systematic review and metaanalysis of oncological and operative outcomes. Ann. Surg. Oncol. 2021;28:7476–7486. doi: 10.1245/s10434-021-09837-8. - DOI - PubMed

LinkOut - more resources